These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
394 related items for PubMed ID: 17105988
1. Survival benefits with diverse chemotherapy regimens for ovarian cancer: meta-analysis of multiple treatments. Kyrgiou M, Salanti G, Pavlidis N, Paraskevaidis E, Ioannidis JP. J Natl Cancer Inst; 2006 Nov 15; 98(22):1655-63. PubMed ID: 17105988 [Abstract] [Full Text] [Related]
2. Comparative survival with diverse chemotherapy regimens for cancer of unknown primary site: multiple-treatments meta-analysis. Golfinopoulos V, Pentheroudakis G, Salanti G, Nearchou AD, Ioannidis JP, Pavlidis N. Cancer Treat Rev; 2009 Nov 15; 35(7):570-3. PubMed ID: 19539430 [Abstract] [Full Text] [Related]
7. Treatment of ovarian cancer using intraperitoneal chemotherapy with taxanes: from laboratory bench to bedside. de Bree E, Theodoropoulos PA, Rosing H, Michalakis J, Romanos J, Beijnen JH, Tsiftsis DD. Cancer Treat Rev; 2006 Oct 15; 32(6):471-82. PubMed ID: 16942841 [Abstract] [Full Text] [Related]
8. Chemotherapy in epithelial ovarian cancer. Wang J, Li AJ, Karlan BY. Curr Womens Health Rep; 2002 Feb 15; 2(1):20-6. PubMed ID: 12112979 [Abstract] [Full Text] [Related]
14. [Intraperitoneal chemotherapy for ovarian cancer]. Noma J, Yoshida N. Gan To Kagaku Ryoho; 2008 Jun 20; 35(6):885-90. PubMed ID: 18633214 [Abstract] [Full Text] [Related]
15. Prognostic impact of hemoglobin levels before and during carboplatin/taxane-based chemotherapy in patients with primary invasive epithelial ovarian cancer. Eichbaum MH, Weiss LM, Bruckner T, Schneeweiss A, Sinn HP, Gebauer G, Fersis N, Kussmaul J, Sohn C. Med Sci Monit; 2009 Apr 20; 15(4):CR156-63. PubMed ID: 19333199 [Abstract] [Full Text] [Related]
16. The results of a quantitative overview of chemotherapy in advanced ovarian cancer: what can we learn? Stewart LA, Parmar MK. Bull Cancer; 1993 Feb 20; 80(2):146-51. PubMed ID: 8173166 [Abstract] [Full Text] [Related]
17. Should intraperitoneal chemotherapy be considered as standard first-line treatment in advanced stage ovarian cancer? Petignat P, du Bois A, Bruchim I, Fink D, Provencher DM. Crit Rev Oncol Hematol; 2007 May 20; 62(2):137-47. PubMed ID: 17188887 [Abstract] [Full Text] [Related]
20. Risk of chemotherapy-induced peripheral neuropathy in large population-based cohorts of elderly patients with breast, ovarian, and lung cancer. Nurgalieva Z, Xia R, Liu CC, Burau K, Hardy D, Du XL. Am J Ther; 2010 May 20; 17(2):148-58. PubMed ID: 19417586 [Abstract] [Full Text] [Related] Page: [Next] [New Search]